• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Metronomic chemotherapy for triple negative breast cancer?三阴性乳腺癌的节拍化疗？
Aging (Albany NY). 2016 Apr;8(4):573-4. doi: 10.18632/aging.100947.
2
Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer.节拍性拓扑替康与帕唑帕尼联合治疗在原发性或晚期转移性三阴性乳腺癌临床前模型中的强效疗效。
Oncotarget. 2015 Dec 15;6(40):42396-410. doi: 10.18632/oncotarget.6377.
3
Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer.节拍性卡培他滨作为三阴性乳腺癌女性的延长辅助化疗
Hematol Oncol Stem Cell Ther. 2015 Mar;8(1):22-7. doi: 10.1016/j.hemonc.2014.11.003. Epub 2014 Nov 26.
4
Case report of long-term survival with metastatic triple-negative breast carcinoma: Treatment possibilities for metastatic disease.转移性三阴性乳腺癌长期生存病例报告：转移性疾病的治疗可能性
Medicine (Baltimore). 2019 Apr;98(16):e15302. doi: 10.1097/MD.0000000000015302.
5
Metronomics in the neoadjuvant and adjuvant treatment of breast cancer.节拍化疗在乳腺癌新辅助和辅助治疗中的应用。
Cancer Lett. 2017 Aug 1;400:259-266. doi: 10.1016/j.canlet.2016.12.041. Epub 2017 Jan 16.
6
Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy.接受节拍化疗治疗的乳腺癌肝转移患者的长期完全缓解。
Tumori. 2014 May-Jun;100(3):e79-82. doi: 10.1700/1578.17238.
7
Elderly woman with triple-negative metastatic breast cancer successfully treated with metronomic capecitabine.一位患有三阴性转移性乳腺癌的老年女性成功接受了卡培他滨节拍化疗。
Anticancer Res. 2014 Aug;34(8):4287-91.
8
Clinical overview of metronomic chemotherapy in breast cancer.乳腺癌节拍化疗的临床概述。
Nat Rev Clin Oncol. 2015 Nov;12(11):631-44. doi: 10.1038/nrclinonc.2015.131. Epub 2015 Aug 4.
9
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.肿瘤浸润淋巴细胞（TILs）是国际乳腺癌研究组（IBCSG）III期随机临床试验22-00中三阴性乳腺癌患者的一个有力预后标志物。
Breast Cancer Res Treat. 2016 Jul;158(2):323-31. doi: 10.1007/s10549-016-3863-3. Epub 2016 Jul 2.
10
Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer.表柔比星、顺铂和持续输注氟尿嘧啶序贯每周紫杉醇联合节拍性环磷酰胺作为三阴性乳腺癌术前治疗的II期研究
Clin Breast Cancer. 2015 Aug;15(4):259-65. doi: 10.1016/j.clbc.2015.03.002. Epub 2015 Mar 18.

引用本文的文献

1
Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies.三阴性乳腺癌中的衰老诱导化疗耐药性及基于进化的治疗策略
Front Oncol. 2021 Jun 24;11:674354. doi: 10.3389/fonc.2021.674354. eCollection 2021.
2
Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?三阴性转移性乳腺癌中的节拍化疗：未来已来？
Int J Breast Cancer. 2017;2017:1683060. doi: 10.1155/2017/1683060. Epub 2017 Dec 3.

本文引用的文献

1
Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer.节拍性拓扑替康与帕唑帕尼联合治疗在原发性或晚期转移性三阴性乳腺癌临床前模型中的强效疗效。
Oncotarget. 2015 Dec 15;6(40):42396-410. doi: 10.18632/oncotarget.6377.
2
Clinical overview of metronomic chemotherapy in breast cancer.乳腺癌节拍化疗的临床概述。
Nat Rev Clin Oncol. 2015 Nov;12(11):631-44. doi: 10.1038/nrclinonc.2015.131. Epub 2015 Aug 4.
3
Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanib.术后辅助或转移性肾细胞癌治疗模型显示米托蒽醌节拍口服联合帕唑帕尼具有强大的抗肿瘤活性。
Sci Transl Med. 2015 Apr 8;7(282):282ra50. doi: 10.1126/scitranslmed.3010722.
4
Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer.晚期卵巢癌在长期临床前强效反应后对口服拓扑替康节拍化疗加帕唑帕尼获得性耐药的分析。
Angiogenesis. 2014 Jul;17(3):661-73. doi: 10.1007/s10456-014-9422-9. Epub 2014 Feb 26.
5
Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor.节拍式口服拓扑替康联合帕唑帕尼在侵袭性小儿实体瘤的小鼠模型中是一种有效的抗血管生成方案。
Clin Cancer Res. 2011 Sep 1;17(17):5656-67. doi: 10.1158/1078-0432.CCR-11-0078. Epub 2011 Jul 25.
6
Metronomic chemotherapy for metastatic prostate cancer: a 'young' concept for old patients?节拍化疗治疗转移性前列腺癌：老药新用？
Drugs Aging. 2010 Sep 1;27(9):689-96. doi: 10.2165/11537480-000000000-00000.
7
Potent preclinical impact of metronomic low-dose oral topotecan combined with the antiangiogenic drug pazopanib for the treatment of ovarian cancer.口服拓扑替康节拍疗法联合抗血管生成药物帕唑帕尼治疗卵巢癌的强大临床前影响。
Mol Cancer Ther. 2010 Apr;9(4):996-1006. doi: 10.1158/1535-7163.MCT-09-0960. Epub 2010 Apr 6.

Metronomic chemotherapy for triple negative breast cancer?

作者信息

Di Desidero Teresa, Kerbel Robert S, Bocci Guido

机构信息

Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa, Pisa, Italy.

出版信息

Aging (Albany NY). 2016 Apr;8(4):573-4. doi: 10.18632/aging.100947.

DOI:10.18632/aging.100947
PMID:27084985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4925814/
Abstract
摘要